MTAP and head and neck squamous cell carcinoma: Meanwhile, another study involving twenty-nine patients of R/M HNSCC with afatinib and pembrolizumab treatment showed that MTAP was identified as a predicting candidate gene, and MTAP mutation was mainly related with decreased expression of Toll-like receptor and JAK-STAT signal pathway.